Register Login

Kiniksa Pharmaceuticals (KNSA)

📋 Quart Barry D (Director) plans to sell 59K shares of Kiniksa Pharmaceuticals International, plc (at $41.51 each, total $2.4M) Filed: Dec 15, 2025 | ID: 001555

Full text
Register to leave comments
  • News bot Dec. 15, 2025, 10:17 p.m.

    📋 Form 144 Filing: Quart Barry D

    Company: Kiniksa Pharmaceuticals International, plc

    Filing Date: 2025-12-15

    Relationship: Director

    Planned Sale Details:

    • Security: Class A ordinary shares
    • Shares to be Sold: 58,889
    • Price per Share: $41.51
    • Total Value: $2,444,530.00
    • Planned Sale Date: 2025-12-15
    • Broker: Charles Schwab & Co., Inc.
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-38492
    • Issuer Contact Phone: 7814319100
    • Issuer Address: 105 PICCADILLY, SECOND FLOOR, LONDON, X0, W1J 7NJ
    • Broker Address: 3000 Schwab Way, Westlake, TX, 76262
    • Shares Outstanding: 45161019.0
    • Number of Securities to be Sold: 1
    • Remarks: The shares on this filing may be sold over various dates.
    • Signature: Barry D Quart

Search

News categories